Acutus Medical Inc
NASDAQ:AFIB
NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

  • LAST PRICE
    0.1634
  • TODAY'S CHANGE (%)
    -0.0034 (-2.0384%)
  • Bid / Lots
    0.1612/ 20
  • Ask / Lots
    0.1699/ 32
  • Open / Previous Close
    0.1630 / 0.1668
  • Day Range
    0.1611
    0.1699
  • 52 Week Range
    0.1600
    1.0899
  • Volume
    133,201

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Apr 1, 2024

      Show headlines and story abstract

    • 4:05PM ET on Monday Apr 01, 2024 by GlobeNewswire
      Companies Mentioned: AFIB

    • 4:05PM ET on Monday Apr 01, 2024 by Dow Jones
      Companies Mentioned: AFIB
      prepayment of debt -- (1,063) Borrowing under new debt, net of fees -- 34,825 Payment of debt issuance costs (490) (626) Proceeds from the exercise of stock options 4 67 Repurchase of common shares to pay employee withholding taxes -- (111) Proceeds from employee stock purchase plan 25 214 Payment of contingent consideration (1,923) (372) ----------- ---------- Net cash used in financing activities - continuing operations (2,384) (11,616) Net cash used in financing activities - discontinued operations (280) -- ----------- ---------- Net cash used in financing activities (2,664) (11,616) ----------- ---------- Effect of exchange rate changes on cash, cash equivalents and restricted cash 2,079 2,909 ----------- ---------- Net change in cash, cash equivalents and restricted cash (5,148) 7,127 Cash, cash equivalents and restricted cash, at the beginning of the period 31,348 24,221 ----------- ---------- Cash, cash equivalents and restricted cash, at the end of the period $ 26,200 $ 31,348 =========== ========== Supplemental disclosure of cash flow information: Cash paid for interest $ 5,012 $ 4,231 Supplemental disclosure of noncash investing and financing activities: Changes between assets and liabilities in discontinued operations $ 5,445 $ (11,341) Accounts receivable from sale of business $ 9,360 $ 17,000 Change in unrealized (gain) loss on marketable securities $ (7) $ (39) Change in unpaid purchases of property and equipment $ -- $ 54 Contingent consideration escrow release $ -- $ 381 Net book value on AcQMap system sales-type leases $ -- $ 244 Amount of debt proceeds allocated to warrant liability $ -- $ 3,379

    • 4:05PM ET on Monday Apr 01, 2024 by Dow Jones
      Companies Mentioned: AFIB

Peers Headlines